Literature DB >> 18230958

Impaired glucose metabolism and cerebrovascular diseases.

David Tanne1.   

Abstract

Ischemic stroke and vascular cognitive impairment are leading causes of long-term disability and constitute a major public health burden and a significant economic burden to health systems. An increasing body of evidence demonstrates that disorders of glucose metabolism including diabetes, and the intermediate states of impaired fasting glucose and impaired glucose tolerance, as well as the cluster of risk factors known as the metabolic syndrome, are important risk factors for ischemic stroke. The associations with accelerated cognitive decline and dementia are also discussed. Underlying pathogenetic mechanisms are myriad but include insulin resistance, endothelial dysfunction, dyslipidemia, chronic inflammation, procoagulability, and impaired fibrinolysis. The high risk associated with diabetes and other disorders of glucose metabolism carries important implications for preventive strategies for cerebrovascular disease and vascular cognitive impairment that are currently under investigation.

Entities:  

Mesh:

Year:  2008        PMID: 18230958     DOI: 10.1159/000115190

Source DB:  PubMed          Journal:  Adv Cardiol        ISSN: 0065-2326


  7 in total

1.  Effects of acupuncture on glycometabolic enzymes in multi-infarct dementia rats.

Authors:  Lan Zhao; Peng Shen; Yingying Han; Xuezhu Zhang; Kun Nie; Haiyan Cheng; Bohong Kan; Guomin Li; Jianchun Yu; Jingxian Han
Journal:  Neurochem Res       Date:  2011-01-30       Impact factor: 3.996

2.  Proteomic analysis of differential proteins related to anti-nociceptive effect of electroacupuncture in the hypothalamus following neuropathic pain in rats.

Authors:  Yonghui Gao; Shuping Chen; Qiuling Xu; Kan Yu; Junying Wang; Lina Qiao; Fanying Meng; Junling Liu
Journal:  Neurochem Res       Date:  2013-04-23       Impact factor: 3.996

3.  Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia/reperfusion injury via their antiglycemic effect.

Authors:  Hossein Ahmadi-Eslamloo; Gholam Abbas Dehghani; Seyed Mostafa Shid Moosavi
Journal:  Metab Brain Dis       Date:  2017-11-19       Impact factor: 3.584

4.  Prevalence, incidence, and mortality of stroke in the chinese island populations: a systematic review.

Authors:  Xiaomei Wu; Bo Zhu; Lingyu Fu; Hailong Wang; Bo Zhou; Safeng Zou; Jingpu Shi
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

5.  An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.

Authors:  Huinan Zhang; Yunhan Liu; Shaoyu Guan; Di Qu; Ling Wang; Xinshang Wang; Xubo Li; Shimeng Zhou; Ying Zhou; Ning Wang; Jingru Meng; Xue Ma
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

6.  The role of glycogen synthase kinase 3 beta in brain injury induced by myocardial ischemia/reperfusion injury in a rat model of diabetes mellitus.

Authors:  Bo Zhao; Wen-Wei Gao; Ya-Jing Liu; Meng Jiang; Lian Liu; Quan Yuan; Jia-Bao Hou; Zhong-Yuan Xia
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

7.  Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Chiara Tomasinelli; Christoph Thiemermann; Giuseppe Boccuzzi; Roberto Fantozzi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.